- Home
- FluxMPS™ Minimum Essential Medium (MEM), Low Glucose, NEAA w/o L-Glutamine, Sodium Bicarbonate, Phenol Red: 1X Liquid
FluxMPS™ Minimum Essential Medium (MEM), Low Glucose, NEAA w/o L-Glutamine, Sodium Bicarbonate, Phenol Red: 1X Liquid
FluxMPS™ DCP-MEM-QBR1X is a Microfluidics Suitable, quadruple-stage ultra-filtered (0.1 µm ×2 + 0.04 µm ×2) MEM Low Glucose + NEAA formulation engineered for primary fibroblasts and related cell models on organ-on-a-chip (OoC) and microphysiological system (MPS) platforms. Also containing Earle's Salts and non-essential amino acids (NEAA), this 1X liquid medium is formulated without L-Glutamine, Sodium Bicarbonate, and Phenol Red for CO2-independent, low-background primary cell applications. NEAA pre-loaded — reduces metabolic burden on primary cells.
- Low Glucose (1.0 g/L) — a physiological carbon source for primary cells sensitive to high-glucose stress.
- NEAA pre-loaded, reducing de novo synthesis burden and ammonia accumulation in primary fibroblasts, neurons, and epithelial cells.
- Quadruple-stage filtration system (0.1 µm ×2 + 0.04 µm ×2) reaching a 0.04 µm final polish.
- Endotoxin release specification < 0.05 EU/mL (LAL assay, USP <85>).
- Formulated without L-Glutamine, Sodium Bicarbonate, and Phenol Red for CO2-independent, low-background primary cell applications.
- Manufactured under an ISO 13485:2016 quality management system, with per-lot Certificate of Analysis.
- Custom pH, glucose concentration, and HEPES supplementation available on request.
- Media familyMEM Low Glucose + NEAA (Earle's Salts)
- Glucose1000 mg/L (1.0 g/L, Low Glucose)
- NEAAPresent
- Formulation[+] Calcium, [+] Magnesium, [+] Glucose, [+] Sodium Pyruvate
[-] L-Glutamine, [-] Sodium Bicarbonate, [-] Phenol Red - AppearanceColorless, clear solution
- pH (USP <791>)7.4
- Osmolality (USP <785>)Contact for specification
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2 (Quadruple-stage)
- Shelf life12 months from date of manufacture, unopened
Engineered for primary cell culture where standard media fails
MEM with Earle's Salts is a primary cell biologist's medium of choice — but conventional 0.22 µm filtered MEM passes mycoplasma-scale particles, subvisible particulates, and endotoxin that can alter primary cell phenotype. FluxMPS™ addresses these failure modes while preserving the full nutritional profile primary cells depend on.
Microchannel-safe purity
0.04 µm final filtration; USP <788> particulate compliance. Low-particulate primary cell media helps prevent chip channel clogging in narrow microfluidic geometries.
Primary cell–optimized formulation
MEM + Earle's Salts + NEAA: an established base for primary fibroblasts, neurons, epithelial, and vascular cells.
Ultrapure-grade water
Ultrapure Type 1 water (18.2 MΩ·cm) is produced under controlled trace-metal and total organic carbon (TOC) limits, supporting consistent lot-to-lot primary cell culture performance.
Below TLR4 endotoxin threshold
< 0.05 EU/mL endotoxin release specification — below the TLR4 activation threshold. In primary cell models, this specification limits the risk of LPS-driven fibroblast activation, neuroinflammatory gene expression, and epithelial barrier disruption.
NEAA reduces metabolic burden
Pre-loaded NEAA reduces the de novo synthesis burden on primary cells, supporting viability in low-serum conditions and reducing ammonia accumulation.
Customization on demand
pH, glucose, HEPES concentration, and component modifications available. Contact support@diagnocine.com.
Quadruple-stage filtration system
Four serial filtration stages — a repeated 0.1 µm prefilter and 0.04 µm final-filter pair, run twice — reaching a final 0.04 µm polish.
-
1
0.1 µm Prefiltration I
Removes large particulate, cell debris, and protein aggregates; protects the first 0.04 µm cartridge.
-
2
0.04 µm Final filtration I
First 0.04 µm pass; retains sub-micron particulates, including the 0.2–0.3 µm size range associated with mycoplasma, that pass a standard 0.22 µm filter. Mycoplasma control is by 0.1 µm/0.04 µm filtration; it is not tested per lot.
-
3
0.1 µm Prefiltration II
Second dedicated prefilter, protecting the second 0.04 µm cartridge.
-
4
0.04 µm Final filtration II — Polish
Ultimate polishing filter; aseptic fill & finish.
Performance vs. conventional media
A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration.
© Diagnocine® — DCP-MEM-QBR1X
Primary cell models and OoC applications
FluxMPS™ DCP-MEM-QBR1X is purpose-built for primary fibroblasts and related cell models, with 0.04 µm filtration purity for microfluidic platform compatibility.
Automated Bioreactors & Robotics
An optional 0.01 µm (10 nm) ultra nano-filtered MPS Grade variant of this formulation is available on request for automated bioreactors and robotic liquid handling — a separate, higher tier from the 0.04 µm Microfluidics Suitable product described on this page (see the Grade note in the Filtration section above).
- Total Particulate Exclusion: 10 nm filtration removes nanoparticulate aggregates.
- Valve & Sensor Protection: Reduces micro-fouling risk in delicate chip geometries.
- Extended Perfusion Stability: Consistent nutrient delivery over long-duration culture.
Inquiry Required: Contact support@diagnocine.com for the 0.01 µm MPS Grade variant.
Neuronal Chips & Brain-on-Chip
MEM + Earle’s Salts + NEAA + low glucose is a physiologically closer base for primary cortical neurons, DRG neurons, and iPSC-derived neuronal networks in compartmentalized chips.
Epithelium-on-Chip
Low-glucose MEM with NEAA supports primary epithelial cells and barrier integrity studies in transwell and microfluidic TEER-monitored platforms.
Primary Fibroblast & Stromal Models
MEM with NEAA is a classical base for primary dermal, lung, and cardiac fibroblasts in low-serum or serum-free OoC conditions.
Vascular Cell Culture
Earle’s salt ionic balance supports vascular smooth muscle cells and primary endothelial co-culture models on vascular-on-chip platforms.
Organ-on-a-Chip & MPS
0.04 µm filtered MEM helps prevent particulate accumulation in sub-100 µm neuronal and epithelial chip microchannels.
Microscopy & Optical Sensing
Phenol red–free formulation and 0.04 µm filtration reduce background particulate for confocal, TEER sensor, and biosensor applications on primary cell chips.
Analytical release specifications
Every lot released against the full specification matrix. CoA: support@diagnocine.com.
| Parameter | Specification |
|---|---|
| Formulation | [+] Calcium, [+] Magnesium, [+] Glucose (1000 mg/L), [+] Sodium Pyruvate | [-] L-Glutamine, [-] Sodium Bicarbonate, [-] Phenol Red (also contains Earle's Salts and NEAA — see Composition tab) |
| Appearance | Colorless, clear solution |
| Glucose | 1000 mg/L (1.0 g/L, Low Glucose) |
| NEAA | Present |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | Contact for specification |
| Total ingredients | 34 components across 4 formulation categories |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL (batch release specification) |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | 0.1 µm mycoplasma-retentive filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> Method 1 | NMT 25/mL |
| Particulate ≥25 µm USP <788> Method 1 | NMT 3/mL |
| Water purity | Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, away from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack |
| CO2 requirement | CO2-independent; supplement with HEPES (15–25 mM) for pH buffering |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Pack sizes: 500 mL, 1000 mL. Contact support@diagnocine.com for other volumes or custom formulations.
Full composition (mg/L)
MEM Low Glucose + NEAA: 34 ingredients verified per lot with CAS numbers where known. NEAA is listed under AMINO ACIDS.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 265.000 |
| Magnesium sulfate anhydrous | 7487-88-9 | 97.720 |
| Potassium chloride | 7447-40-7 | 400.000 |
| Sodium chloride | 7647-14-5 | 6800.000 |
| Sodium dihydrogen phosphate anhydrous | 7558-80-7 | 122.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| Glycine | 56-40-6 | 7.500 |
| L-Alanine | 56-41-7 | 8.900 |
| L-Arginine hydrochloride | 1119-34-2 | 126.000 |
| L-Asparagine monohydrate | 5794-13-8 | 15.000 |
| L-Aspartic acid | 56-84-8 | 13.300 |
| L-Cystine dihydrochloride | 30925-07-6 | 31.300 |
| L-Glutamic acid | 56-86-0 | 14.700 |
| L-Histidine hydrochloride monohydrate | 5934-29-2 | 42.000 |
| L-Isoleucine | 73-32-5 | 52.000 |
| L-Leucine | 61-90-5 | 52.000 |
| L-Lysine hydrochloride | 657-27-2 | 72.500 |
| L-Methionine | 63-68-3 | 15.000 |
| L-Phenylalanine | 63-91-2 | 32.000 |
| L-Proline | 147-85-3 | 11.500 |
| L-Serine | 56-45-1 | 10.500 |
| L-Threonine | 72-19-5 | 48.000 |
| L-Tryptophan | 73-22-3 | 10.000 |
| L-Tyrosine disodium salt dihydrate | 69847-15-0 | 51.900 |
| L-Valine | 72-18-4 | 46.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 1.000 |
| D-Ca-Pantothenate | 137-08-6 | 1.000 |
| Folic acid | 59-30-3 | 1.000 |
| Nicotinamide | 98-92-0 | 1.000 |
| Pyridoxal hydrochloride | 65-22-5 | 1.000 |
| Riboflavin | 83-88-5 | 0.100 |
| Thiamine hydrochloride | 67-03-8 | 1.000 |
| OTHERS | ||
| i-Inositol | 87-89-8 | 2.000 |
| D-Glucose | 50-99-7 | 1000.000 |
| Sodium Pyruvate | 113-24-6 | 110.000 |
Manufacturing & compliance
Every FluxMPS™ product is manufactured and released under a multi-layer quality system.
ISO 13485:2016 Quality Management
Manufactured under ISO 13485:2016–certified facilities. Final QA at Diagnocine R&D Center, Totowa, NJ, USA.
Ultrapure Type 1 Water
18.2 MΩ·cm, produced under controlled trace-metal and TOC limits.
ISO Class 5 Fill & Finish
Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.
Micro-Batch Precision
Small-batch, per-lot tested — no blending. Certificate of Analysis available for every batch.
Endotoxin — USP <85> BET
LAL assay; release specification < 0.05 EU/mL per batch.
Particulate — USP <788> Method 1
NMT 25/mL (≥10 µm), NMT 3/mL (≥25 µm), by light obscuration.
Osmolality — USP <785>
Contact for specification.
Documentation & CoA
Full CoA with raw-material traceability available for every lot on request.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
How DCP-MEM-QBR1X compares
FluxMPS™ DCP-MEM-QBR1X vs. conventional 0.22 µm–filtered MEM Low Glucose + NEAA formulations.
| Parameter | DCP-MEM-QBR1X (FluxMPS™) | Conventional MEM Low Glucose (0.22 µm filtered) |
Standard DMEM (0.22 µm) |
|---|---|---|---|
| Grade | Microfluidics Suitable (0.04 µm) | Not applicable — 0.22 µm single-stage filtration | |
| MEM + NEAA without L-Glutamine, Bicarbonate, and Phenol Red — CO2-independent, low-background primary cell base | check_circle Yes | cancel No | cancel No |
| Final filtration pore size | 0.04 µm | 0.22 µm | 0.22 µm |
| Number of filtration stages | 4 (Quadruple) | 1 | 1 |
| Mycoplasma-retentive filtration | check_circle Yes (0.1 µm/0.04 µm) | cancel No | cancel No |
| NEAA included | check_circle Yes | Optional add-on | cancel No |
| Endotoxin (release specification, USP <85>) | < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
|
| USP <788> particulate tested | check_circle Yes (Method 1) | cancel No | cancel No |
| Water quality | Type 1, 18.2 MΩ·cm | Purified water | Purified water |
| Manufacturing QMS | ISO 13485:2016 | ISO 9001 or none | ISO 9001 or none |
| Microfluidic channel compatibility | check_circle Yes — Microfluidics Suitable | cancel Risk of clogging | cancel Risk of clogging |
| Custom formulation available | check_circle Yes | cancel No | cancel No |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ DCP-MEM-QBR1X.
Supporting literature
Key publications supporting MEM Low Glucose + NEAA formulations in primary cell OoC applications.
- Eagle H. Amino acid metabolism in mammalian cell cultures. Science. 1959;130:432–437. doi:10.1126/science.130.3373.432
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
- Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
- Campisi M, et al. 3D self-organized microvascular model of the human blood-brain barrier. Biomaterials. 2018;180:117–129. doi:10.1016/j.biomaterials.2018.07.014
- Jang KJ, et al. Human kidney proximal tubule-on-a-chip. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
- Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
- Luni C, et al. High-efficiency cellular reprogramming with microfluidics. Nat Methods. 2016;13:446–452. doi:10.1038/nmeth.3832
- Sung JH, et al. Microfabricated mammalian organ systems. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j
